Cowen Downgrades Raptor Pharmaceuticals (RPTP) to Market Perform
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Cowen downgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Outperform to Market Perform with a price target of $9.00.
Shares of Raptor Pharmaceuticals closed at $8.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cowen Upgrades Dick's Sporting Goods (DKS) to Outperform
- JPMorgan Downgrades ARIAD Pharmaceuticals (ARIA) to Underweight
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesCowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!